Prosperity Wealth Management Inc. Makes New $63,000 Investment in BioVie Inc. (NASDAQ:BIVI)

Prosperity Wealth Management Inc. purchased a new position in shares of BioVie Inc. (NASDAQ:BIVI) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 31,650 shares of the company’s stock, valued at approximately $63,000.

Separately, Sanders Morris Harris LLC bought a new stake in BioVie during the fourth quarter worth about $85,000. Institutional investors own 4.59% of the company’s stock.

BioVie Stock Up 0.5 %

Shares of BIVI stock opened at $1.05 on Thursday. The business has a 50-day moving average price of $1.77 and a two-hundred day moving average price of $2.20. BioVie Inc. has a 12-month low of $1.02 and a 12-month high of $7.50. The firm has a market cap of $19.37 million, a P/E ratio of -0.11 and a beta of 0.51.

BioVie (NASDAQ:BIVI) last released its earnings results on Tuesday, February 11th. The company reported ($0.46) earnings per share for the quarter.

About BioVie

BioVie Inc, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease.